Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STAT3 in Cancer—Friend or Foe?
Haifeng Zhang, Raymond Lai
Cancers (2014) Vol. 6, Iss. 3, pp. 1408-1440
Open Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Katie L. Owen, Natasha K. Brockwell, Belinda S. Parker
Cancers (2019) Vol. 11, Iss. 12, pp. 2002-2002
Open Access | Times Cited: 537
The potential and controversy of targeting STAT family members in cancer
Yannick Verhoeven, Sam Tilborghs, Julie Jacobs, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 41-56
Open Access | Times Cited: 314
Systems and Synthetic microRNA Biology: From Biogenesis to Disease Pathogenesis
Hironori Matsuyama, Hiroshi Suzuki
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 132-132
Open Access | Times Cited: 212
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
Bettina Wingelhofer, Heidi A. Neubauer, Peter Valent, et al.
Leukemia (2018) Vol. 32, Iss. 8, pp. 1713-1726
Open Access | Times Cited: 209
Environmental immune disruptors, inflammation and cancer risk
Patricia A. Thompson, Mahin Khatami, Carolyn J. Baglole, et al.
Carcinogenesis (2015) Vol. 36, Iss. Suppl 1, pp. S232-S253
Open Access | Times Cited: 201
Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review
Zahra Memariani, Syed Qamar Abbas, Syed Shams ul Hassan, et al.
Pharmacological Research (2020) Vol. 171, pp. 105264-105264
Closed Access | Times Cited: 175
STAT3 and apoptosis challenges in cancer
Nazanin Fathi, Golnaz Rashidi, Ali Khodadadi, et al.
International Journal of Biological Macromolecules (2018) Vol. 117, pp. 993-1001
Closed Access | Times Cited: 169
Sulconazole Induces PANoptosis by Triggering Oxidative Stress and Inhibiting Glycolysis to Increase Radiosensitivity in Esophageal Cancer
Lu-Xin Liu, Jing-Hua Heng, Dan-Xia Deng, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 6, pp. 100551-100551
Open Access | Times Cited: 47
Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature
Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, Habbanakuppe D. Preetham, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 157-182
Closed Access | Times Cited: 124
The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
Wei Yuan, Qiyi Zhao, Zhiliang Gao, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3347-3360
Open Access | Times Cited: 104
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer
Moumita Chatterjee, Edgar Ben‐Josef, Dafydd G. Thomas, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 100
STAT3, a Master Regulator of Anti-Tumor Immune Response
Cédric Rébé, François Ghiringhelli
Cancers (2019) Vol. 11, Iss. 9, pp. 1280-1280
Open Access | Times Cited: 100
Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
Sareshma Sudhesh Dev, Syafiq Asnawi Zainal Abidin, Reyhaneh Farghadani, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 96
The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment
Nakho Chang, Sun Hee Ahn, Doo‐Sik Kong, et al.
Molecular and Cellular Endocrinology (2017) Vol. 451, pp. 53-65
Closed Access | Times Cited: 92
Integration of phytochemicals and phytotherapy into cancer precision medicine
Thomas Efferth, Mohamed E.M. Saeed, Elhaj Mirghani, et al.
Oncotarget (2017) Vol. 8, Iss. 30, pp. 50284-50304
Open Access | Times Cited: 92
STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer
Nagendra Awasthi, Clifford Liongue, Alister C. Ward
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 88
STAT3: Versatile Functions in Non-Small Cell Lung Cancer
Julian Mohrherr, Iris Z. Uras, Herwig P. Moll, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1107-1107
Open Access | Times Cited: 82
Molecular pathogenesis of the myeloproliferative neoplasms
Graeme Greenfield, Mary Frances McMullin, Ken Mills
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 82
Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells
Aveen N. Adham, Sara Abdelfatah, Alaadin M. Naqishbandi, et al.
Phytomedicine (2020) Vol. 80, pp. 153371-153371
Closed Access | Times Cited: 76
STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential
Sarah Q. To, Rhynelle S. Dmello, Anna K. Richards, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 429-429
Open Access | Times Cited: 55
Inflammaging is driven by upregulation of innate immune receptors and systemic interferon signaling and is ameliorated by dietary restriction
Seyed Mohammad Mahdi Rasa, Francesco Annunziata, Anna Křepelová, et al.
Cell Reports (2022) Vol. 39, Iss. 13, pp. 111017-111017
Open Access | Times Cited: 45
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer
Yufei Yang, Dakui Luo, Yang Shao, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 100-122
Open Access | Times Cited: 39
JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus
Arturo Valle‐Mendiola, Adriana Gutiérrez‐Hoya, Isabel Soto‐Cruz
Genes (2023) Vol. 14, Iss. 6, pp. 1141-1141
Open Access | Times Cited: 28
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway
Jan Pěnčík, C. Philippe, Michaela Schlederer, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 27
TNFR2 Stimulation Promotes Mitochondrial Fusion via Stat3- and NF-kB–Dependent Activation of OPA1 Expression
Jinliang Nan, Hengxun Hu, Yong Sun, et al.
Circulation Research (2017) Vol. 121, Iss. 4, pp. 392-410
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top